semaglutide development history Transforming obesity: The advancement of multi-receptor drugs: Cell A big win for Wegovy:

Precautions Here are some health conditions that may require close monitoring if on semaglutide treatment

Those who were overweight or obese and taking the drug to lose weight were seven times more at risk

Concerns are escalating about the risk of gastroparesis, a condition commonly known as stomach paralysis, which is often associated with these medications

That depends.[Weight loss medication] should be very individualized based on your symptoms, medical conditions, eating habits, basal metabolic rate, and what [weight loss solutions] youve tried in the past, says Janese Laster, M.D., an obesity medicine specialist at Georgetown University Hospital

For branded Wegovy, that means 0.25 mg weekly